Glimtaz

Glimtaz 15mg/1mg Tablet is a prescription medicine for adults with type 2 diabetes. It helps lower blood sugar levels when diet and exercise alone are not enough, reducing the risk of diabetes complications.

Individuals should not take Glimtaz 15mg/1mg Tablet if they have type 1 diabetes, diabetic ketoacidosis, severe heart failure, bladder cancer, serious liver problems, or if they are allergic to either pioglitazone, glimepiride, or other sulfonylurea medicines.

Yes, pioglitazone (present in Glimtaz 15mg/1mg Tablet) may cause fluid retention, which can lead to or worsen heart failure. You should inform your doctor immediately if you develop shortness of breath, rapid weight gain, or swelling in your legs or ankles.

Some studies suggest that long-term use of Glimtaz 15mg/1mg Tablet may be linked to an increased risk of bladder cancer. You should tell your doctor if you have a history of bladder cancer or notice blood in your urine.

Yes, Glimtaz 15mg/1mg Tablet can rarely cause liver injury. You should contact your doctor right away if you experience symptoms such as unusual tiredness, loss of appetite, dark urine, or yellowing of the skin, or eyes.

Yes, Glimtaz 15mg/1mg Tablet may increase the risk of bone fractures, particularly in women. Your doctor may recommend bone health monitoring during treatment.

Before starting Glimtaz 15mg/1mg Tablet, you should inform your doctor if you have heart disease, liver problems, kidney disease, bladder cancer, bone health concerns, or a history of severe low blood sugar.